; and (2) by inserting after subsection (e) the following: (f) (1) The Attorney General shall, not less frequently than quarterly, make the following information available to manufacturers and distributors registered under this title through the Automated Reports and Consolidated Orders System, or any subsequent automated system developed by the Drug Enforcement Administration to monitor selected controlled substances: (A) The total number of distributors registered under this title that distribute controlled substances to a pharmacy or practitioner registered under section 303(f), aggregated by the name and address of each pharmacy and practitioner registrant. (B) The total quantity and type of opioids distributed, listed by Administration Controlled Substances Code Number, to each pharmacy and practitioner registered under section 303(f). (2) The information required to be made available under paragraph (1) shall be made available not later than the 15th day of the first month following the quarter to which the information relates. (3) (A) All manufacturers and distributors registered under this title shall be responsible for reviewing the information made available by the Attorney General under this subsection. (B) In determining whether to initiate proceedings under this title against a manufacturer or distributor registered under this title based on the failure of the registrant to maintain effective controls against diversion or otherwise comply with the requirements of this title or the regulations issued thereunder, the Attorney General may take into account that the information made available under this subsection was available to the registrant. (4) All of the reports required under this subsection shall be provided in electronic format. . (b) Cooperative arrangements Section 503 of the Controlled Substances Act ( 21 U.S.C. 873 ) is amended— (1) by striking subsection (c) and inserting the following: (c) (1) The Attorney General shall, once every 6 months, prepare and make available to regulatory,